vancomycin has been researched along with warfarin in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (23.68) | 18.7374 |
| 1990's | 2 (5.26) | 18.2507 |
| 2000's | 7 (18.42) | 29.6817 |
| 2010's | 19 (50.00) | 24.3611 |
| 2020's | 1 (2.63) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Hu, W; Lv, F; Shi, W; Xing, D; Yang, L; Yang, S; Yang, Y; Zhao, Z | 1 |
| Creemer, CN; Dai, M; Davis, DC; Kyei-Baffour, K; Mohammad, H; Seleem, MN; Younis, W | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Abdelghany, TM; Fayed, E; Mayhoub, AS; Mohammad, H; Seleem, MN; Yahia, E | 1 |
| Abd Rabo Moustafa, MM; Abdelghany, TM; Eissa, IH; Elshafeey, A; Mayhoub, AS; Mohammad, H; Qassem, OA; Seleem, MN; Younis, W | 1 |
| Ghiaty, A; Hagras, M; Hegazy, YA; Mandour, MS; Mayhoub, AS; Mohammad, H; Seleem, MN | 1 |
| Cui, A; Kou, S; Li, Z; Sun, L; Yi, H; Zhang, S | 1 |
| Tawfik, AF | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Braveny, I; Machka, K; Milatovic, D | 1 |
| Braveny, I; Machka, K | 1 |
| Joly, P; Van der Auwera, P | 1 |
| Breyer, S; Georgopoulos, A; Hirschl, AM; Rotter, ML; Stanek, G | 1 |
| Angaran, DM; Arom, KV; Dias, VC; Kersten, TG; Lindsay, WG; Nicoloff, DM; Northrup, WF | 1 |
| Chandrasekar, PH; DeLorenzo, W; Levine, DP; Unowsky, J | 1 |
| Dibb, WL; Digranes, A; Salveson, A | 1 |
| Angaran, DM; Arom, KV; Dias, VC; Kersten, TE; Lindsay, WG; Nicoloff, DM; Northrup, WF | 1 |
| Johnson, JL; Liacouras, CA; Tung, JY | 1 |
| Fuller, RS; Krysan, DJ; Rockwell, NC | 1 |
| Jarmalaviciene, R; Kornysova, O; Maruska, A | 1 |
| Ding, GS; Tang, AN | 1 |
| Almafragi, A; Dujardin, K; Vandorpe, J | 1 |
| Joshi, SD; Kulkarni, MV; More, UA; Revankar, HM | 1 |
| Hadjiphilippou, S; Huang, DY | 1 |
| Aoyama, H; Hatano, T; Kuroda, T; Orabi, MA | 1 |
| Barras, MA; Donagher, J; Martin, JH | 1 |
| Imakyure, O; Irie, K; Kamimura, H; Matsuo, K; Mishima, K; Nakamura, T; Nakamura, Y; Nakano, T; Ogata, K; Sato, K | 1 |
| Chang, D; Kim, KT; Lindberg, E; Winssinger, N | 1 |
| Agarwal, A; Fritz, A; Guru, PK | 1 |
2 review(s) available for vancomycin and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Individualised medicine: why we need Bayesian dosing.
Topics: Aged; Bayes Theorem; Dose-Response Relationship, Drug; Enoxaparin; Humans; Male; Precision Medicine; Pulmonary Embolism; Vancomycin; Warfarin | 2017 |
1 trial(s) available for vancomycin and warfarin
| Article | Year |
|---|---|
The comparative influence of prophylactic antibiotics on the prothrombin response to warfarin in the postoperative prosthetic cardiac valve patient. Cefamandole, cefazolin, vancomycin.
Topics: Aged; Cefamandole; Cefazolin; Clinical Trials as Topic; Drug Interactions; Female; Heart Valve Prosthesis; Humans; Hypoprothrombinemias; Male; Middle Aged; Postoperative Period; Prospective Studies; Prothrombin; Random Allocation; Surgical Wound Infection; Tetrazoles; Vancomycin; Vitamin K; Warfarin | 1987 |
35 other study(ies) available for vancomycin and warfarin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Oligopeptides; Structure-Activity Relationship | 2014 |
Discovery and characterization of aryl isonitriles as a new class of compounds versus methicillin- and vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Caco-2 Cells; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Humans; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Molecular Structure; Nitriles; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin Resistance | 2015 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Phenylthiazole antibiotics: A metabolism-guided approach to overcome short duration of action.
Topics: Anti-Bacterial Agents; Cells, Cultured; Drug Resistance, Bacterial; Drug Stability; Half-Life; Humans; Keratinocytes; Methicillin-Resistant Staphylococcus aureus; Structure-Activity Relationship; Thiazoles | 2017 |
Diphenylurea derivatives for combating methicillin- and vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Caenorhabditis elegans; Carbanilides; Drug Resistance, Bacterial; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2017 |
Investigating the Antibacterial Activity of Biphenylthiazoles against Methicillin- and Vancomycin-Resistant Staphylococcus aureus (MRSA and VRSA).
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Structure-Activity Relationship; Thiazoles; Vancomycin | 2017 |
Design, synthesis, and antibacterial activity of derivatives of Tryptophanyl-tRNA synthetase inhibitor indolmycin.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Escherichia coli; Indoles; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcus aureus; Staphylococcus epidermidis; Tryptophan-tRNA Ligase | 2022 |
Effects of vancomycin, teicoplanin, daptomycin and coumermycin on normal immune capabilities.
Topics: Aminocoumarins; Animals; Anti-Bacterial Agents; Coumarins; Daptomycin; Glycopeptides; Humans; Immunity, Cellular; Leukocytes; Male; Mice; Mice, Inbred BALB C; Organ Size; Peptides; Phagocytosis; Spleen; Teicoplanin; Vancomycin | 1991 |
Evaluation of teicoplanin and vancomycin disk susceptibility tests.
Topics: Aminocoumarins; Anti-Bacterial Agents; Bacteria; Corynebacterium; Coumarins; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Enterobacteriaceae; Fusidic Acid; Glycopeptides; Microbial Sensitivity Tests; Pseudomonas; Streptococcus; Teicoplanin; Vancomycin | 1986 |
In vitro interactions of carumonam in combination with coumermycin, teicoplanin, flucloxacillin and vancomycin.
Topics: Aminocoumarins; Anti-Bacterial Agents; Aztreonam; Bacteria; Cloxacillin; Coumarins; Drug Therapy, Combination; Enterobacter; Floxacillin; Glycopeptides; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Serratia marcescens; Teicoplanin; Vancomycin | 1987 |
Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.
Topics: Aminocoumarins; Anti-Bacterial Agents; Coumarins; Daptomycin; Glycopeptides; Microbial Sensitivity Tests; Peptides; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1987 |
Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
Topics: Aminocoumarins; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Coumarins; DNA-Directed RNA Polymerases; Drug Interactions; Glycopeptides; Humans; Rifabutin; Rifampin; Rifamycins; Staphylococcus aureus; Teicoplanin; Topoisomerase II Inhibitors; Vancomycin | 1987 |
Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
Topics: Aminocoumarins; Animals; Anti-Bacterial Agents; Coumarins; Drug Resistance, Microbial; Male; Methicillin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Ofloxacin; Oxazines; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1988 |
In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
Topics: Aminocoumarins; Animals; Anti-Bacterial Agents; Coumarins; Drug Combinations; Female; Fusidic Acid; Methicillin; Mice; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1986 |
Coumermycin: in vitro activity against 251 clinical isolates of bacteria compared with the activities of eight other antibacterial agents.
Topics: Aminocoumarins; Ampicillin; Anti-Bacterial Agents; Clindamycin; Cloxacillin; Coumarins; Doxycycline; Erythromycin; Gram-Positive Bacteria; Humans; Netilmicin; Penicillin G; Staphylococcus; Streptococcus; Vancomycin | 1986 |
The influence of prophylactic antibiotics on the warfarin anticoagulation response in the postoperative prosthetic cardiac valve patient. Cefamandole versus vancomycin.
Topics: Blood Coagulation; Cefamandole; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Hypoprothrombinemias; Male; Postoperative Complications; Postoperative Period; Premedication; Retrospective Studies; Surgical Wound Infection; Thromboembolism; Vancomycin; Warfarin | 1984 |
Portal-mesenteric pylephlebitis with hepatic abscesses in a patient with Crohn's disease treated successfully with anticoagulation and antibiotics.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Anticoagulants; Clindamycin; Crohn Disease; Female; Gentamicins; Heparin; Humans; Liver Abscess; Mesenteric Veins; Portal Vein; Thrombosis; Tomography, X-Ray Computed; Vancomycin; Warfarin | 1996 |
Synthesis of peptidyl methylcoumarin esters as substrates and active-site titrants for the prohormone processing proteases Kex2 and PC2.
Topics: Binding, Competitive; Carbonic Anhydrases; Coumarins; Electrophoresis, Capillary; Esters; Ligands; Proprotein Convertase 2; Proprotein Convertases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Substrate Specificity; Subtilisins; Time Factors; Vancomycin | 2000 |
A simplified synthesis of polymeric nonparticulate stationary phases with macrocyclic antibiotic as chiral selector for capillary electrochromatography.
Topics: Anti-Bacterial Agents; Bupivacaine; Chromatography, Micellar Electrokinetic Capillary; Cross-Linking Reagents; Molecular Structure; Polymers; Stereoisomerism; Tartrates; Thalidomide; Vancomycin; Warfarin | 2004 |
Capillary electrochromatographic separation of racemates on a norvancomycin-bonded monolithic column under reversed-phase conditions.
Topics: Capillary Electrochromatography; Microscopy, Electron, Scanning; Silicon Dioxide; Stereoisomerism; Vancomycin; Warfarin | 2008 |
Calciphylaxis in a cardiac patient without renal disease.
Topics: Alcoholism; Anti-Bacterial Agents; Anticoagulants; Calciphylaxis; Clindamycin; Diphosphonates; Female; Heart Diseases; Humans; Kidney Failure, Chronic; Meropenem; Middle Aged; Risk Factors; Thienamycins; Vancomycin; Warfarin | 2009 |
Synthesis, biological evaluation and docking studies of 4-aryloxymethyl coumarins derived from substructures and degradation products of vancomycin.
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus niger; Candida albicans; Coumarins; Enterococcus faecalis; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Novobiocin; Vancomycin | 2013 |
An unusually extensive internal jugular vein thrombosis.
Topics: Anti-Bacterial Agents; Anticoagulants; Diagnosis, Differential; Drug Therapy, Combination; Female; Gentamicins; Heparin; Humans; Jugular Veins; Middle Aged; Renal Dialysis; Vancomycin; Venous Thrombosis; Warfarin | 2013 |
Structures of two new flavonoids and effects of licorice phenolics on vancomycin-resistant Enterococcus species.
Topics: Anti-Bacterial Agents; Coumarins; Enterococcus; Flavonoids; Glycyrrhiza; Microbial Sensitivity Tests; Molecular Structure; Phenols; Plant Extracts; Vancomycin; Vancomycin Resistance | 2014 |
Effects of Teicoplanin on the PT-INR Controlled by Warfarin in Infection Patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; International Normalized Ratio; Male; Middle Aged; Protein Binding; Prothrombin Time; Retrospective Studies; Serum Albumin; Teicoplanin; Vancomycin; Warfarin | 2017 |
Accelerating Turnover Frequency in Nucleic Acid Templated Reactions.
Topics: Coumarins; Fluorescence; Fluorescent Dyes; Nucleic Acid Hybridization; Nucleic Acids; Oligonucleotides; Peptide Nucleic Acids; Vancomycin | 2018 |
A miraculous recovery:
Topics: Animals; Anti-Bacterial Agents; Anticoagulants; Ants; Bartonella Infections; Brain Diseases; Diagnosis, Differential; Doxycycline; Heart Arrest; Humans; Insect Bites and Stings; Male; Middle Aged; Pulmonary Embolism; Tomography, X-Ray Computed; Vancomycin; Warfarin | 2018 |